Skip to main content

Table 2 The use of PROMs in different settings within knee and hip OA

From: Implementing patient-reported outcomes in clinical decision-making within knee and hip osteoarthritis: an explorative review

Type of PROMa Surgical: n (%) Non-surgical: n (%) Both surgical and non-surgical: n (%) Unspecified treatment: n (%) Total:
n (%)
Generic
 EQ-5D 52 (43.7) 7 (20.6) 3 (33.3) 1 (6.7) 63 (35.6)
 SF-12 39 (32.8) 9 (26.5) 1 (11.1) 4 (26.7) 53 (29.9)
 SF-36 27 (22.7) 7 (20.6) 5 (55.6) 7 (46.7) 46 (26.0)
 PROMIS 0 (0) 8 (23.5) 0 (0) 3 (20.0) 11 (6.2)
 Otherb 1 (0.8) 3 (8.8) 0 (0) 0 (0) 4 (2.3)
 Subtotal 119 (100) 34 (100) 9 (100) 15 (100) 177 (100)
Disease-specific
 WOMAC 70 (22.3) 23 (39.7) 9 (34.6) 20 (31.3) 122 (26.4)
 KOOS 37 (11.8) 16 (27.6) 5 (19.2) 14 (21.9) 72 (15.6)
 OKS 57 (18.2) 3 (5.2) 2 (7.7) 4 (6.3) 66 (14.3)
 KSS 45 (14.3) 1 (1.7) 0 (0) 2 (3.1) 48 (10.4)
 OHS 37 (11.8) 0 (0) 2 (7.7) 1 (1.6) 40 (8.7)
 HOOS 24 (7.6) 3 (5.2) 3 (11.5) 5 (7.8) 35 (7.6)
 HHS 19 (6.1) 0 (0) 4 (15.4) 3 (4.7) 26 (5.6)
 FJS 17 (5.4) 0 (0) 0 (0) 0 (0) 17 (3.7)
 Otherc 8 (2.5) 12 (20.7) 1 (3.8) 15 (23.4) 36 (7.8)
 Subtotal 314 (100) 58 (100) 26 (100) 64 (100) 462 (100)
Domain-specific
 VAS 16 (88.9) 9 (69.2) 2 (100) 6 (50) 33 (73.3)
 Otherd 2 (11.1) 4 (30.8) 0 (0) 6 (50) 12 (26.7)
 Subtotal 18 (100) 13 (100) 2 (100) 12 (100) 45 (100)
Total 451 105 37 91 684
  1. aThe full names of the PROMs are available in Additional file 2.
  2. bSANE, PGI-S/C
  3. cLEFS, TLKS, IKDC, ASES, KOS, PGAP (O2MS), ICOAP, LAI, HAAS, JHEQ, AKPS (KUJALA), OAQOL, OAHQOL (AMIQUAL), HOS, IHOT-33, ASAP
  4. dBPI, NRS, PD-Q, PIQ, PASE, CPGS, LATE-LIFE DFI